Eckfeldt JH, Karger AB, Miller WG, Rynders GP, Inker LA. Performance in measurement of serum cystatin C by laboratories participating in the College of American Pathologists 2014 CYS survey. Arch Pathol Lab Med. 2015;139(7):888-893. doi: 10.5858/arpa.2014-0427-CP.
Piéroni L, Delanaye P, Boutten A, et al; Société Française De Biologie Clinique (SFBC). A multicentric evaluation of IDMS-traceable creatinine enzymatic assays. Clin Chim Acta. 2011;412(23-24): 2070-2075.
Grubb A, Blirup-Jensen S, Lindstr öm V, Schmidt C, Althaus H, Zegers I; IFCC Working Group on Standardisation of Cystatin C (WG-SCC). First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med. 2010;48(11):1619-1621.
González-Antun?a A, Rodŕ?guez-González P, Ohlendorf R, Henrion A, Delatour V, Garć?a Alonso JI. Determination of Cystatin C in human serum by isotope dilution mass spectrometry using mass overlapping peptides. J Proteomics. 2015;112:141-155.
Shlipak MG, Matsushita K, Ä rnlöv J, et al; CKD Prognosis Consortium. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369(10):932-943.